MedMira Inc (MIR) - Cash Flow Conversion Efficiency

Latest as of January 2026: 0.011x

Based on the latest financial reports, MedMira Inc (MIR) has a cash flow conversion efficiency ratio of 0.011x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-267.69K ≈ $-193.64K USD) by net assets (CA$-24.03 Million ≈ $-17.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MIR cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

MedMira Inc - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how MedMira Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MedMira Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MedMira Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
TJ media Co. Ltd
KQ:032540
0.033x
Big 5 Sporting Goods Corporation
NASDAQ:BGFV
-0.258x
Workhorse Group Inc
NASDAQ:WKHS
-0.245x
iCRAFT Co. Ltd
KQ:052460
0.170x
Tocvan Ventures Corp
F:TV3
-0.046x
Daewon Co. Ltd
KQ:007680
0.059x
Opticis Company Limited
KQ:109080
0.013x
Hidropar Hareket Kontrol Teknolojileri Merkezi Sanayi ve Ticaret A.S.
IS:HKTM
-0.323x

Annual Cash Flow Conversion Efficiency for MedMira Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of MedMira Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see MIR stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-07-31 CA$-22.56 Million
≈ $-16.32 Million
CA$-3.15 Million
≈ $-2.28 Million
0.139x -14.42%
2024-07-31 CA$-18.04 Million
≈ $-13.05 Million
CA$-2.94 Million
≈ $-2.13 Million
0.163x +93.17%
2023-07-31 CA$-15.03 Million
≈ $-10.87 Million
CA$-1.27 Million
≈ $-917.07K
0.084x -44.69%
2022-07-31 CA$-12.36 Million
≈ $-8.94 Million
CA$-1.88 Million
≈ $-1.36 Million
0.152x +375.09%
2021-07-31 CA$-15.72 Million
≈ $-11.37 Million
CA$-504.64K
≈ $-365.05K
0.032x +58.11%
2020-07-31 CA$-15.56 Million
≈ $-11.26 Million
CA$-315.90K
≈ $-228.51K
0.020x -70.85%
2019-07-31 CA$-13.52 Million
≈ $-9.78 Million
CA$-941.13K
≈ $-680.80K
0.070x -0.23%
2018-07-31 CA$-11.40 Million
≈ $-8.25 Million
CA$-795.41K
≈ $-575.38K
0.070x -66.83%
2017-07-31 CA$-8.98 Million
≈ $-6.50 Million
CA$-1.89 Million
≈ $-1.37 Million
0.210x -60.61%
2016-07-31 CA$-7.66 Million
≈ $-5.54 Million
CA$-4.09 Million
≈ $-2.96 Million
0.534x +75.38%
2015-07-31 CA$-7.70 Million
≈ $-5.57 Million
CA$-2.35 Million
≈ $-1.70 Million
0.305x -56.23%
2014-07-31 CA$-6.69 Million
≈ $-4.84 Million
CA$-4.66 Million
≈ $-3.37 Million
0.696x +685.62%
2011-07-31 CA$-19.11 Million
≈ $-13.83 Million
CA$-1.69 Million
≈ $-1.22 Million
0.089x -44.03%
2010-07-31 CA$-16.66 Million
≈ $-12.05 Million
CA$-2.64 Million
≈ $-1.91 Million
0.158x +25.16%
2009-07-31 CA$-16.00 Million
≈ $-11.57 Million
CA$-2.02 Million
≈ $-1.46 Million
0.126x -45.46%
2008-07-31 CA$-13.94 Million
≈ $-10.08 Million
CA$-3.23 Million
≈ $-2.34 Million
0.232x +40.86%
2007-07-31 CA$-12.78 Million
≈ $-9.24 Million
CA$-2.10 Million
≈ $-1.52 Million
0.165x -82.43%
2006-07-31 CA$-8.05 Million
≈ $-5.82 Million
CA$-7.54 Million
≈ $-5.45 Million
0.937x +70.96%
2005-07-31 CA$-9.80 Million
≈ $-7.09 Million
CA$-5.37 Million
≈ $-3.89 Million
0.548x +4.46%
2004-07-31 CA$-5.87 Million
≈ $-4.25 Million
CA$-3.08 Million
≈ $-2.23 Million
0.525x -61.59%
2003-07-31 CA$-2.19 Million
≈ $-1.58 Million
CA$-2.99 Million
≈ $-2.16 Million
1.366x +178.17%
2002-07-31 CA$-7.45 Million
≈ $-5.39 Million
CA$-3.66 Million
≈ $-2.64 Million
0.491x -51.47%
2001-07-31 CA$-6.01 Million
≈ $-4.35 Million
CA$-6.08 Million
≈ $-4.40 Million
1.012x +8.71%
2000-07-31 CA$-3.28 Million
≈ $-2.37 Million
CA$-3.05 Million
≈ $-2.21 Million
0.931x --

About MedMira Inc

V:MIR Canada Biotechnology
Market Cap
$33.00 Million
CA$45.61 Million CAD
Market Cap Rank
#23486 Global
#868 in Canada
Share Price
CA$0.07
Change (1 day)
+0.00%
52-Week Range
CA$0.06 - CA$0.10
All Time High
CA$0.70
About

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more